The VelocityShares VIX ETN Collapse

On February 5, 2018, the VelocityShares Daily Inverse VIX Short-Term ETN (XIV), one of the most actively traded securities on American exchanges, imploded spectacularly. In hours, a product that had been profitable for nearly every shareholder since inception lost 95% of its value and was liquidated. The event provides an unparalleled case study in how ETN structure combines with product design to create risks that most investors don't perceive until they materialize catastrophically.

The Pre-Crisis Context: The VIX and XIV Product

To understand the February 2018 collapse, the history of the VIX and how XIV worked must be understood. The VIX, formally the Cboe Volatility Index, measures the implied volatility of out-of-the-money put and call options on the S&P 500. It's commonly described as "the investor fear index"—when market participants are anxious about stock declines, they bid up the prices of index put options, raising the VIX. When sentiment is euphoric, option prices fall and the VIX drops.

The VIX is unusual as a market indicator. It's not directly tradeable—you can't buy the VIX the way you can buy a share of stock or a barrel of oil. Instead, investors trade VIX futures contracts and options. VIX futures come in monthly expirations. The first month's contract is called the "front month" or "near term" contract. Subsequent months are "deferred" contracts.

A critical structural characteristic of VIX futures is that they typically trade in backwardation during normal market conditions. The near-term contract trades higher than deferred contracts, reflecting the fact that current volatility is elevated relative to expected future volatility. This term structure—backwardation in the VIX futures curve—is normal and persistent. The VIX itself might be 15, but the front-month VIX futures contract might trade at 17, and the second-month contract at 16. The deferred contracts trade even lower, at 15 or 14.

The Strategy and Its Initial Success

VelocityShares designed XIV to profit from this backwardated VIX term structure. The fund held short positions in front-month VIX futures contracts. It was betting that the roll yield from backwardation would profit the fund even if the VIX itself stayed flat.

The logic is simple: if the fund is short the front-month VIX contract at 17 and that contract will eventually expire and be replaced by the current second-month contract trading at 16, the fund profits by 1 point. If the backwardation is 1-2 points per month, the fund earned 12-24 points annually just from rolling the position—not from any particular view that volatility would fall.

However, the fund needed to maintain this short position continuously. As front-month contracts expired, new contracts needed to be shorted. The fund prospectus outlined this rolling process. To generate a daily price update that investors could easily understand, VelocityShares calculated what daily holding the short VIX position would have generated if the VIX curve remained static. The resulting price mechanism is complex but relevant: the daily change in XIV's price roughly corresponded to the inverse of the change in the VIX during normal conditions.

This created an appealing product narrative: "short volatility exposure" that was "less risky" than holding options because it didn't have theta decay or gamma risk. Instead, it had rolling yield from backwardation. During the years 2013-2017, volatility gradually declined from the post-financial crisis elevated levels toward historically low levels. The VIX spent 95% of this period between 10 and 20, with many days below 15.

XIV soared during this period. In 2017, XIV returned 160% as volatility continued falling. In 2016, during a period when "volatility ETNs are hedges against stock volatility," XIV was one of the best-performing securities on the market. Performance like this attracted new investors constantly. By early 2018, XIV had roughly $4 billion in assets and was trading millions of shares daily.

The Implied Risk Nobody Took Seriously

Embedded in the XIV prospectus was a clear risk: if volatility spiked dramatically, the short VIX futures positions would lose massive amounts of money, possibly exceeding the fund's assets. The prospectus also contained a provision allowing the issuer, Credit Suisse (which operated VelocityShares products), to liquidate the fund if the issuer's funding costs exceeded certain thresholds or if credit risk became excessive.

Despite these disclosures, the risk was largely ignored. Retail investors, using online brokers and casual trading platforms, could buy XIV like any stock. Many treated it as a swing-trading vehicle or a hedge to be held for short periods. Financial advisors recommended XIV or similar products to clients seeking "volatility hedge" or "tail risk" positions. Few investors ran simulations of what would happen if the VIX spiked 50% or 100% in a day, though that's exactly what the product's payoff structure implied was possible.

The prospectus technically disclosed the risk. But reading and understanding a prospectus requires time and knowledge. For retail investors, XIV was simply a security trading on an exchange with high volumes and attractive recent returns. The narrative was that volatility was structurally lower because central banks had eliminated tail risk (the "Greenspan Put" extended and amplified). Nobody seriously expected a 2008-style volatility event.

January 26, 2018: The First Warning

The first warning sign came on January 26, 2018, when the VIX spiked from 12 to 20 in a single trading day. This wasn't a crisis level—the VIX at 20 is still below its long-term average—but it was the largest single-day jump in the VIX since June 2016. XIV dropped 11% in that single session.

This might have been instructive. An 11% single-day loss on a position that had returned 160% in the prior year was a warning that extreme volatility was possible. But XIV rebounded in subsequent days as volatility fell again. Investors who held through the dip were made whole within two weeks. This reinforced the narrative that volatility spikes were temporary and trading XIV was profitable over rolling periods.

February 5, 2018: The Implosion

On February 5, the S&P 500 fell 3.6% in a single session—the largest single-day percentage decline since the election in November 2016. More importantly, it was a sharp, unexpected move. The stock market had been booming. No major geopolitical event or economic data release triggered the drop. Instead, it reflected a sudden shift in risk sentiment.

The VIX, which had been around 17 at the open, spiked to 36 by the close. This wasn't the largest VIX move in history—during the 2008 crisis and March 2020, the VIX spiked to 80+—but it was a massive move by recent standards. And for a short-volatility position that had been built on the assumption that volatility would gradually decline, a spike to 36 was catastrophic.

The XIV short positions in VIX futures lost enormous amounts of money. By 3:00 PM on February 5, the fund's value had fallen approximately 80% from its morning close. Credit Suisse faced a situation where it had short VIX futures positions worth billions that had lost the vast majority of their value, and the fund's assets were insufficient to cover the loss.

At 3:30 PM on February 5, Credit Suisse announced that it was liquidating XIV effective immediately. The statement said funding costs had become prohibitively expensive and that the issuer's risk exposure had become untenable. The final liquidation price was set at a level that reflected the XIV value at approximately 4:00 PM on February 5, after the initial shock had subsided somewhat but volatility was still extremely elevated.

Investors holding XIV faced a 95% loss. The loss was final and immediate. There was no option to hold and wait for recovery, no gradual deterioration. The security went from liquid to liquidated in hours. Those who tried to sell XIV during the trading day on February 5 faced chaotic conditions. The bid-ask spread widened dramatically as buyers disappeared. Many orders couldn't be executed at any price.

The Mechanics of Why XIV Imploded Faster Than VIX Spiked

Understanding why XIV lost 95% while the VIX "only" doubled from 17 to 36 requires understanding the inverse relationship's mechanics. XIV wasn't simply a linear short VIX bet. The way the fund was structured, it had inherent leverage.

XIV held short positions in multiple months of VIX futures contracts (not just the front month). As the front month expired, it would roll into the next month. But during a volatility spike, two things happened simultaneously. First, the deferred contracts (which normally trade lower due to backwardation) spiked upward—sometimes even to levels above the front-month contract (known as "flattening" of the curve or even "inverting" into contango). This meant the fund's rolling strategy, which had been profitable during backwardation, became catastrophically expensive during the spike.

Second, the leverage in the fund's position meant that a doubling of the VIX translated to something approaching a 4-5x inverse loss, not a 2x inverse loss. This is because the fund was essentially short leveraged VIX exposure, and leverage works both directions.

Regulatory and Issuer Response

After February 5, regulators examined ETN structures intensively. The SEC released risk alerts about ETNs. FINRA issued guidance reminding brokers that ETNs aren't the same as ETFs and carry counterparty and structural risks. Academic researchers and financial economists published analyses showing that XIV's structure contained tail risk that the pricing mechanism didn't reflect.

Lawsuits were filed against Credit Suisse alleging inadequate disclosure, market manipulation, and bad faith liquidation. The lawsuits claimed that Credit Suisse had exercised its liquidation right opportunistically to protect itself, rather than holding positions until markets recovered. Settlements eventually resulted in roughly 1.5 billion dollars in payments to affected investors, though these settlements compensated only a fraction of losses.

More broadly, XIV's implosion triggered a reassessment of leveraged and inverse ETNs and ETFs. Regulatory guidance now recommends that retail investors avoid these products entirely, and many brokers have imposed restrictions on opening new positions in leveraged/inverse funds without explicit risk acknowledgment.

The Cascade of Bankruptcies and Closures

In the aftermath, several other volatility ETNs faced pressure. XXV and SVXY, two competing short-volatility products, experienced sharp declines but survived because they were issued by more robust institutions and had different structural details. However, both products saw significant redemptions and were eventually shut down.

The broader lesson extended beyond volatility products. Investors and advisors began to question whether any ETN was worth the counterparty risk, particularly if an ETF alternative existed. This shifting perception has affected iPath commodity ETNs (issued by Barclays), which still operate but have faced steady asset declines as investors reallocate to ETF equivalents.

The Persistent Risk

Over six years after the XIV collapse, the structural risks remain embedded in ETN design. Any ETN carrying the liquidation clause faces the same risk: during the precise moment when the fund's value falls sharply (precisely when investors want exit), the issuer might exercise its right to liquidate, forcing a loss at the worst possible moment.

This is fundamentally different from an ETF. An ETF might decline 50% during a market crash, but shareholders retain the option to hold or sell at market prices. An ETN issuer can take that choice away by liquidating the fund. For commodity ETNs holding futures contracts, this risk is mitigated because the underlying commodity futures markets are very liquid and can absorb the forced sale of any reasonably sized position. But for more exotic products or those with thinner underlying markets, the risk remains severe.

The XIV collapse remains one of the most instructive financial events for understanding product structure risk, leverage, and the distinctions between different investment vehicles. For commodity investors, it demonstrates that ETN benefits must be weighed against counterparty risk and structural risks that can activate suddenly during market stress.

References

• SEC Office of Investor Education and Advocacy. "What You Should Know About Structured Notes." Investor Alert, 2018.
• FINRA Regulatory Notice 18-11. "Risk Disclosures Associated with Leveraged and Inverse ETNs."
• Federal Reserve Board. "Credit Suisse Regulatory Capital Analysis." Banking Regulation and Supervision Reports, 2018.
• U.S. Court of Appeals for the Second Circuit. "In re XIV Liquidation Proceedings." Case litigation summaries, 2018-2021.